<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Guildowns Group Practice</h1>
        This is some intro text.

        <h2>Prescribing where Guildowns Group Practice is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81010&amp;numIds=0205051AC&amp;denomIds=2.5.5&amp;selectedTab=summary">Perindopril with calcium channel blocker</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Angiotensin-converting enzyme inhibitors</td>
      <td>3060</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>7.08</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81010&amp;numIds=0205051ACAAADAD&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Perindopril erbumine 8mg / Amlodipine 5mg tablets : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81010&amp;numIds=0203020P0&amp;denomIds=2.3.2&amp;selectedTab=summary">Mexiletine hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>13</td>
      <td>Drugs for arrhythmias</td>
      <td>149</td>
      <td>0.09</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>6.81</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81010&amp;numIds=0203020P0AAAIAI&amp;denomIds=2.3.2&amp;selectedTab=summary" target="_blank">Mexiletine 100mg capsules : 13</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81010&amp;numIds=0101010I0&amp;denomIds=1.1.1&amp;selectedTab=summary">Magnesium oxide</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3</td>
      <td>Antacids and simeticone</td>
      <td>4</td>
      <td>0.75</td>
      <td>0.05</td>
      <td>0.19</td>
      <td>3.74</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81010&amp;numIds=0101010I0AAACAC&amp;denomIds=1.1.1&amp;selectedTab=summary" target="_blank">Magnesium oxide 160mg capsules : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81010&amp;numIds=0205051M0&amp;denomIds=2.5.5&amp;selectedTab=summary">Perindopril erbumine</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1259</td>
      <td>Angiotensin-converting enzyme inhibitors</td>
      <td>3060</td>
      <td>0.41</td>
      <td>0.09</td>
      <td>0.10</td>
      <td>3.26</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81010&amp;numIds=0205051M0AAAAAA&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Perindopril erbumine 2mg tablets : 198</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81010&amp;numIds=0205051M0AAABAB&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Perindopril erbumine 4mg tablets : 487</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81010&amp;numIds=0205051M0AAAFAF&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Perindopril erbumine 8mg tablets : 574</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81010&amp;numIds=0208020AA&amp;denomIds=2.8.2&amp;selectedTab=summary">Edoxaban</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>742</td>
      <td>Oral anticoagulants</td>
      <td>1729</td>
      <td>0.43</td>
      <td>0.09</td>
      <td>0.10</td>
      <td>3.25</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81010&amp;numIds=0208020AAAAABAB&amp;denomIds=2.8.2&amp;selectedTab=summary" target="_blank">Edoxaban 30mg tablets : 349</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81010&amp;numIds=0208020AAAAACAC&amp;denomIds=2.8.2&amp;selectedTab=summary" target="_blank">Edoxaban 60mg tablets : 387</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81010&amp;numIds=0208020AAAAAAAA&amp;denomIds=2.8.2&amp;selectedTab=summary" target="_blank">Edoxaban 15mg tablets : 6</a></div></td></tr></tbody></table>

        <h2>Prescribing where Guildowns Group Practice is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81010&amp;numIds=0606020A0&amp;denomIds=6.6.2&amp;selectedTab=summary">Alendronic acid</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>398</td>
      <td>Bisphosphonates and other drugs</td>
      <td>611</td>
      <td>0.65</td>
      <td>0.87</td>
      <td>0.09</td>
      <td>-2.37</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81010&amp;numIds=0606020A0AAACAC&amp;denomIds=6.6.2&amp;selectedTab=summary" target="_blank">Alendronic acid 70mg tablets : 390</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81010&amp;numIds=0606020A0AAAFAF&amp;denomIds=6.6.2&amp;selectedTab=summary" target="_blank">Alendronic acid 70mg/100ml soln unit dose sugar free : 8</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81010&amp;numIds=0309010C0&amp;denomIds=3.9.1&amp;selectedTab=summary">Codeine phosphate</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Cough suppressants</td>
      <td>5</td>
      <td>0.00</td>
      <td>0.76</td>
      <td>0.35</td>
      <td>-2.17</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81010&amp;numIds=0205020M0&amp;denomIds=2.5.2&amp;selectedTab=summary">Moxonidine</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Centrally-acting antihypertensive drugs</td>
      <td>3</td>
      <td>0.00</td>
      <td>0.64</td>
      <td>0.34</td>
      <td>-1.91</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAG7ElEQVR4nO3dXYwVZx3H8e9AKcLSFgWlbF8YRYqNhqZpQ0IRaNKWmkzbCyNqjKYxGHxLuNIwJiZ60TSTthdN2gZSlZbe9aIvUSZN0QglaaBVUG98oasMaqCsLAhCQan+vXhme2YPs2XP63Nm5/dJnpyz27L7y7I/5jnzPDMnMDNEpB5m+A4gIv2jwovUiAovUiMqvEiNqPAiNaLCi9SICi9SIyq8SI2o8CI1osKL1EhnhQ8C7csVqZArfAcQkYYwToeBzwDrgRuAIeACsA/YC+zMkuhiu19fhRcZAGGcrgS2ACuAnwHPACPAOWAesBrYACTA8na/jwov4lEYpzcATwKLcWX+fJZE/y35X0eAHWGc3tzJ9ws6ujw2CAyzoJMAInUUxulM4JvAd4AfAjuyJOr5OTEd4UX6LIzTTwE/Ag4DK7MkGu3X91bhRfokjNMPAN8HvgBszpLolX5n0Dq8SB+EcboOOAjMBW71UXbQEV6kp8I4/SDwCHA78GCWRL/ymUeFF+mBME5nAF8BfgBsA77Vyfp5t6jwIl0Wxula4DHgCHBXlkSHPUd6jwov0gVhnAbAp3FLbHOA72ZJ9JrXUCVUeJEO5GfeNwCbgfPAQ8DP+7Gm3g4VXqRFYZzOAtYAX8Lte98FbMqS6Ddeg02BdtqJXEY+Xf8YcCdwD27q/mvgeeCnWRKd85euNSq8SJMwThcDt+GW0m4DbgFGgd3AL4HdWRJd8JewfSq81FIYp0PAEuCjwCcKYykwBhzAHcUPAL/LkugdT1G7SoWXaSWffs8DFgHX5uM6XLmXACHuyrQLuGWzw8AfC+PwIKyX94oKL5UQxumVNEq8mEaZi2MRbuvqWeBt4Hj+eBTIcAU/Ahyb5BLUaU+Fl4EQxukC4CbczR1uAq6nUe4FwLs0CnwsH28XxnHgeJVOoPmgwkvfhHE6B/g4jVKPFzwETgGHCuOvNMo9liXR/zxEnnZUeOmq/MYONzKx1OMjAN7CFfpPNMp9JEuid70ErhkVXlqWnxhbyKWlXg58CPc6ubnUI5pu+9dx4cMtO0eAfwIngD8AbwKvZ0n0t64kFC/COL0C9zp6KW7TSfFxGLd01VzqQ8CJQd1WKt0p/FXAfOAjwCeBlbgdSReBF3H36lL5PcuPykO4v6fi+HDJ5xbmf+zvwJ+Bv+SP48+P6jV1NfVsSh/G6TLcRQVfBX4PbAV26Rele8I4nc3EwpaVd/zzs3HLVaOF8Y+mj8fHSb2mnp56/ho+vxHAvbg7dC4Hfgxsz5JorP1vPH2FcToPtxQ1jFuWmuyIfDXwby5f3lHcNLuSW0Glu/p60i6M0yXAJuDLuH3JT/m+5U+/5Fs5h2mUuez5fNxR+Gg+juej7Kh8Vq+VpVVeztLnU9HPAd/GXaK7FXghS6Iz7YfxI4zTubx/kYdxRT5Ho8jHCs+LH59RiaWXvC/LhXF6K/A14H7gDeBl4NUsiU508nU7zDQLN20u7sde1PR4LXAN7qYHZeUtPj+tIssg8F74cXnJ7gbuw91U4BTuDfT24076HWp3HTffh70gHwtLHhfRKPL4Ns5RJu7HLnuuIkulDEzhi/IlpBBYhVvmuxm3sWM2br3/BO6E1UXgP/kAd+HEUP44FzeVnpP/97H8z42VPC+W+aRWEmS6GsjCTybftjl+pL6yMGbhtm2eA94pjNNZEp3vVz6RQVepwotIZ/RWUyI1osKL1IgKL1IjKrxIjXRU+AC+3q0g/RAEwSbfGVpVtcxVywvVy9xJ3k6P8JX6QVG9vFC9zFXLC9XL7K3wIlIhKrxIjXRa+Ke7kqJ/qpYXqpe5anmhepnbztvZTjsRqRRN6UVqpKX3hw+CYC1wBzBqZtuDIPgs7i6mI2b2Ui8Cdqok84O4m22+Yma7/aa7VHPe/HPbgGfNbL/XcJMo+RmvwV3puN/M9vpNd6mSvBuBqwDM7HGv4SYRBMGdwDfM7Iv5xxtxl3S/ZmavT/XrtHqEX2VmCe6+agDLzOxR3KWrg2pCZjPbAWzD3XJ5EE3Im/+jusdrostr/r14AHdjkEG9zLg570xceUb9RXp/ZrYH+G3hUwvN7GHce9VPWauFb37BX4UTABMyBkEwBGwEnvMT57Kaf6YrcH+pqz1kmarmzFeb2RPAeh9hpqA57wwz+x5utloVbXWvpZN2+VRoFXASOIh7+92lwFtm9nI7AXqtJPNmYAT4hZnt85mtTHNeMzuQT+cuDPiUvvn3IgROm9lPPEYrVZJ3He5+Cv8ys4E8Yx8EwS3AQ7g7QD0H3IOblextZUqvs/QiNaKz9CI1osKL1IgKL1IjKrxIjajwIjWiwovUiAovUiMqvEiNqPAiNaLCi9SICi9SI/8H1P+kcsGoO9oAAAAASUVORK5CYII="></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81010&amp;numIds=0209000A0&amp;denomIds=2.9&amp;selectedTab=summary">Aspirin</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1035</td>
      <td>Antiplatelet drugs</td>
      <td>1847</td>
      <td>0.56</td>
      <td>0.65</td>
      <td>0.06</td>
      <td>-1.49</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAIB0lEQVR4nO3df4ycRR3H8ffTlh+lgEQtGNR2QNDGaokRo6VCQasxTq3EYCTCH1ZrwR8xgCLThIYGDJ1aAlgVKxGDaVBILDlop1SRUFq1WEU0AX9GGYlWbaNAUAq2dPxjpvW67l33bp/dmb3n+0qe7N11u/u5u/3c8zyz8zxPFUJACNEMk3IHEEL0jxReiAaRwgvRIFJ4IRpECi9Eg0jhhWgQKbwQDSKFF6JBpPBCNIgUXogGkcKXoKpkfrPoiym5A4hyKONeA8wFzkjLXmADsMFb/Zec2UQ9Kjl4pgBVFQihyvX0yrgzgKuB2cBm4JdpmQa8D1gEPAVc7q3ekSun6J4UvgSZCq+MOxNYDpwCfAFY761+cYT7zgduAe4Hlnurn+1bUFEbKXwJ+lx4ZdxZxKKfSCz6Pd7q/R38v6OBZcBFwBJv9ZZe5hT1k8KXoA+FV8ZVwHxi0acB1wGbvNVjfgEo4+YA30nL9Z38sRBlkMKXoMeFV8adB1wL7CcW/YHxFL3lMY8D1gLTgYu91bu6Dip6Tgpfgh4VXhn3MuAmYBZwpbf6oZofvwKWAJ8HPuit/kWdjy/qJ4UvQc2FT0X8ELASWAOsGWkwrqbnmwesA67wVg/16nlE96TwJaix8Mq4KcCXgDcAH/FWP1HH43bwvAoYAu4EVnW7yyB6Q2baTSDKuJcQJ8ocASzoV9kBvNUeOBs4F7hRGSevrQLJL2WCUMbNBLYBPwAu8Vbv7XeG9N78IuBVwDfS1oYoiGzSl6DLTXpl3KuJRV/mrb67vmDjzjMZuBU4Afiwt/qFzJFEImv4AaeMOxn4PoWUHSANEC4BngTuThN2RAGk8ANMGXcSsewrSin7AWnQ7grgMWBIGTc1cySBFH5gKeOmE+e1r/JW35U7Tzup9AZ4BLhXGXdM5kiNJ4UfQMq4lxLX7Dd7q9flzjOaVPqrgR8DG5Vx0zJHajQZtCvBGAbtlHEnENfst3mr1/Y2WL2UccuBBYD2Vv8rd54mkjX8AFHGHU88Xn3doJUdwFt9HTH/5vS9iD6Twg8IZdyxgAO+661ekzvPeHmrVwL3AN9Txr08d56mkcIPgDTYtQG4z1t9Q+483fJWrwZuB7am02qJPpF9+BKMsg+f3sO+F9jurb6mv8F6Sxn3XuArxMk5D+fO0wSyhi9Y2s/dSHxba0XeNPXzVm8CLgDuUMZdlDtPE8gavgRt1vBpUo0D7pwIm/GjUca9kniU3a+Ay7zVezJHmrBkDV+gtF/7EPE49glddoB0CuzziGfG/ZEy7vTMkSYsWcOXYNgaPu3XfhX4pLf6vrzB+k8Zt5B40o5biBOL9mWONKFI4UtQVUFdtfEo4HrgHcCF3urfZU6VTZpJeAMwB/i4t/rRzJEmDCl8CWLhdwA7iOeeez53pBIo4xYQR/G3Add4q3dmjjTwpPAZpTXZtX7Vwk+pqzbqNGothlHGHQksBT4H3AGs9lY/nTfV4JLCZ5AOFb0EuAz4ml+10Oa81NQgSG9RfhZYDHwbuMlb/fe8qQaPFL6P0pFilwKfJs6cs97qnbmvLTdI0nn7LgU+QXzbcnU6n57ogBS+D5RxpxJfpBcC64Eveqv/evAOUvgxS1tJi4HLge3E8wI8njdV+aTwPZI2QRcCFxMv1vh14Fve6qf+785S+HFTxh1B/EN6JbCb+HMe8lb/J2uwQknha6SMmwG8C3g/8CZgE3AX8OCo52mXwnctXXxjHnFs5BzSde2BLXISzf+Rwo9TeoGdBrwVeBvwTmAv8eQUDtja8aQRKXyt0iW2NHELax7wKPEtz58CP/NW784YLysp/GGkYp8IvA54PTCbeFWX1xLPyvoT4ovpwUP2y8dCCt8z6W29M9PyFuDNxNNn/wH4Tcvie3lJrhJI4Tm4H3gScDIwg1juA8sM4r7hb4FfE8/C+jjw+9r2E6XwfZV+36cSL7I5i/h7ngUo4DnAp+WJYbc7gd3e6n/3O2+dxlR4ZdwFwIEX5ki3Iz5XB/8+CZgMTEm3kzv8fKT7HAlMTcvRwz4e/nkFvAj8jfhL/TOx3AeWJ3v+V18KX4x0GeyZxIFWlW5PAV5B3NI7BtgH7EnLc8M+3gO8QNy1G77sa/O1Tpf9h8vsrb6/0++vmDV8VVVLQwi35s7RTsnZQPJ1o+RsUH++kg6PXZo7wChKzgaSrxslZ4Oa85VUeCFEj0nhhWiQkgpf7H4UZWcDydeNkrNBzfmKGbQTQvReSWt4IUSPTcn1xFVVnQOcBewKIXwzfW0tcHsIIfs5ylvzVVW1Anga2BRCyHr6qTbZzgbmAg+HELbmzAZt851PnKU4NYSwPG+6tvk+BhwHEEK4ubBsHyXODPxTCGF9t4+fcw0/N4RggekAVVV9ANiSMU+rQ/IB/wBKufJpa7ZFxEkfh52k0SeH5AshDBGnspZyWevWn99k4kzLXfkiHdSabUYI4UbgPXU8eM7Ctw4ezAHeTjzYoQSH5AshfBlYSbxwQm6tP7vjU7535wjTRruBoTeGEB7re5L2WvNNCiEsA0q47FVrtgeqqvoM8EwdD55t0C5tuswF/gn8PITwSFVV5wLPF7RJfzAf8WCZ2cAPQwibC8s2kzgN9JkQwm0ZowFt8/0RWJzWVNm1yTefOMX62dyz7tpkO5Z4ROb2EMK2rh9fRumFaA4ZpReiQaTwQjSIFF6IBpHCC9EgUnghGkQKL0SDSOGFaBApvBANIoUXokGk8EI0iBReiAb5L2xNLp6zH8r+AAAAAElFTkSuQmCC"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81010&amp;numIds=0209000A0AAABAB&amp;denomIds=2.9&amp;selectedTab=summary" target="_blank">Aspirin 75mg dispersible tablets : 760</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81010&amp;numIds=0209000A0AAAKAK&amp;denomIds=2.9&amp;selectedTab=summary" target="_blank">Aspirin 75mg gastro-resistant tablets : 258</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81010&amp;numIds=0209000A0AAAJAJ&amp;denomIds=2.9&amp;selectedTab=summary" target="_blank">Aspirin 75mg tablets : 17</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81010&amp;numIds=0703022M0&amp;denomIds=7.3.2&amp;selectedTab=summary">Medroxyprogesterone acetate</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>79</td>
      <td>Parenteral progestogen-only contraceptives</td>
      <td>121</td>
      <td>0.65</td>
      <td>0.88</td>
      <td>0.16</td>
      <td>-1.41</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81010&amp;numIds=0703022M0BBABAB&amp;denomIds=7.3.2&amp;selectedTab=summary" target="_blank">Depo-Provera 150mg/1ml inj pre-filled syringes : 79</a></div></td></tr></tbody></table>
        <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
        <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
    </div>

</body>

</html>